QSAM Biosciences, Inc.
A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| Weiss Ratings | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 10.24% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -6.10% | |||
| 52-Week Low % Change | 9.67% | |||
| Price | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $14,910.00 | |||
| 52-Week Low Price | $12,766.00 | |||
| 52-Week Low Price (Date) | Mar 20, 2024 | |||
| 52-Week High Price (Date) | Apr 25, 2024 | |||
| Valuation | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $14,000.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -8.74 | |||
| Market Cap Category | -- | |||
| Dividends and Shares | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 512 343 4558 | |||
| Address | Plaza 1 Austin, TX 78759 | |||
| Website | www.qsambio.com | |||
| Country | United States | |||
| Year Founded | 2004 | |||
| Profitability | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -238.10% | |||
| Return on Equity | -- | |||
| Income Statement | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -3.94M | |||
| Net Income (TTM) | -4.39M | |||
| Net Income Avl. to Common (TTM) | -4.39M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 58.85% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.39M | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | 1.71M | |||
| Total Preferred Equity (Q) | 0.51 | |||
| Total Equity (Q) | 672.30K | |||
| Current Ratio (Q) | 1.651 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | 1.71M | |||
| Total Current Liabilities (Q) | 1.03M | |||
| Total Debt (Q) | 7.50K | |||
| Total Liabilities (Q) | 1.03M | |||
| Total Common Equity (Q) | 163.10K | |||
| Cash Flow | A408WA - | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 4.01M | |||
| Net Change in Cash (TTM) | 1.16M | |||
| Levered Free Cash Flow (TTM) | -2.51M | |||
| Cash from Operations (TTM) | -2.85M | |||
